SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 134 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,657,020 | +913.4% | 114,923 | +1049.2% | 0.00% | – |
Q2 2023 | $262,200 | +6706.9% | 10,000 | -93.3% | 0.00% | -100.0% |
Q1 2023 | $3,852 | +8.7% | 149,655 | +9.8% | 0.00% | 0.0% |
Q4 2022 | $3,544 | -99.9% | 136,246 | -20.1% | 0.00% | -33.3% |
Q3 2022 | $4,867,000 | +210.4% | 170,597 | +167.9% | 0.00% | +200.0% |
Q2 2022 | $1,568,000 | +68.8% | 63,672 | +324.8% | 0.00% | – |
Q4 2021 | $929,000 | -68.0% | 14,990 | -67.2% | 0.00% | -100.0% |
Q3 2021 | $2,903,000 | -49.4% | 45,757 | -41.3% | 0.00% | -50.0% |
Q1 2021 | $5,738,000 | -34.3% | 77,990 | -35.2% | 0.00% | -33.3% |
Q4 2020 | $8,731,000 | +15.0% | 120,393 | -24.4% | 0.01% | -33.3% |
Q3 2020 | $7,589,000 | -38.1% | 159,205 | -45.5% | 0.01% | -47.1% |
Q2 2020 | $12,264,000 | +647.3% | 292,008 | +380.6% | 0.02% | +325.0% |
Q1 2020 | $1,641,000 | +645.9% | 60,760 | +961.7% | 0.00% | – |
Q4 2019 | $220,000 | -97.5% | 5,723 | -98.6% | 0.00% | -100.0% |
Q3 2019 | $8,750,000 | – | 403,613 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |